These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ASAS consensus definition of early axial spondyloarthritis. Navarro-Compán V; Benavent D; Capelusnik D; van der Heijde D; Landewé RB; Poddubnyy D; van Tubergen A; Baraliakos X; Van den Bosch FE; van Gaalen FA; Gensler L; López-Medina C; Marzo-Ortega H; Molto A; Pérez-Alamino R; Rudwaleit M; van de Sande M; Sengupta R; Weber U; Ramiro S Ann Rheum Dis; 2024 Aug; 83(9):1093-1099. PubMed ID: 37321799 [TBL] [Abstract][Full Text] [Related]
5. Update on recommendations for eligibility of government subsidization of biologic disease-modifying antirheumatic drugs for the treatment of axial spondyloarthritis in Singapore. Phang KF; Lahiri M; Fong WWS; Leong KH; Leung YY; Lim AYN; Lui NL; Manghani M; Tan TC; Santosa A; Sriranganathan MK; Suresh E; Teng GG; Cheung PP Int J Rheum Dis; 2020 Feb; 23(2):165-173. PubMed ID: 31762225 [TBL] [Abstract][Full Text] [Related]
6. Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement. Marchesoni A; D'Angelo S; Anzidei M; Bortolotti R; Cantini F; Caramella D; Carotti M; Chimenti MS; Delle Sedie A; Egan CG; Fabbroni M; Frediani B; Fusaro E; Galeazzi M; Gallazzi MB; Gentileschi S; Gentili F; Gerli R; Gilio M; Iannone F; La Paglia E; Lubrano E; Macarini L; Olivieri I; Pellerito R; Ramonda R; Salvarani C; Scarano E; Scarpa R; Spaggiari L; Spanò A; Zawaideh JP; Mazzei MA; Clin Exp Rheumatol; 2019; 37(4):575-584. PubMed ID: 30557127 [TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. Armuzzi A; Felice C; Lubrano E; Cantini F; Castiglione F; Gionchetti P; Orlando A; Salvarani C; Scarpa R; Marchesoni A; Vecchi M; Olivieri I; Dig Liver Dis; 2017 Dec; 49(12):1298-1305. PubMed ID: 28822731 [TBL] [Abstract][Full Text] [Related]
8. Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert's Document Based on a Systematic Literature Review and Extended Delphi Process. García-Vicuña R; Juanola X; Navarro-Compán V; Moreno-Ramos MJ; Castillo-Gallego C; Moreno M; Galíndez E; Montoro M; Gómez I; Rebollo-Laserna FJ; Loza E Rheumatol Ther; 2023 Oct; 10(5):1215-1240. PubMed ID: 37450194 [TBL] [Abstract][Full Text] [Related]
9. Clinical practice recommendations for the use of imaging in the diagnosis and management of axial spondyloarthritis in Taiwan. Wei JC; Chen HH; Hsieh TY; Lan HH; Tseng JC; Liu CH; Chen YC; Tsai WC; Wu HH; Chou CT Int J Rheum Dis; 2020 Jan; 23(1):24-36. PubMed ID: 31833212 [TBL] [Abstract][Full Text] [Related]
10. Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. van der Heijde D; Dougados M; Landewé R; Sieper J; Maksymowych WP; Rudwaleit M; Van den Bosch F; Braun J; Mease PJ; Kivitz AJ; Walsh J; Davies O; Bauer L; Hoepken B; Peterson L; Deodhar A Rheumatology (Oxford); 2017 Sep; 56(9):1498-1509. PubMed ID: 28498975 [TBL] [Abstract][Full Text] [Related]
11. The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis. Deodhar A; Strand V; Kay J; Braun J Ann Rheum Dis; 2016 May; 75(5):791-4. PubMed ID: 26768406 [TBL] [Abstract][Full Text] [Related]
12. Using a modified Delphi process to establish clinical consensus for the diagnosis, risk assessment and abatacept treatment in patients with aggressive rheumatoid arthritis. Caporali R; Carletto A; Conti F; D'Angelo S; Foti R; Gremese E; Govoni M; Iannone F; Pellerito R; Sinigaglia L Clin Exp Rheumatol; 2017; 35(5):772-776. PubMed ID: 28281459 [TBL] [Abstract][Full Text] [Related]
13. Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis. Truong SL; McEwan T; Bird P; Lim I; Saad NF; Schachna L; Taylor AL; Robinson PC Rheumatol Ther; 2022 Feb; 9(1):1-24. PubMed ID: 34962620 [TBL] [Abstract][Full Text] [Related]
14. Recommendations by the Spanish Society of Rheumatology on the Use of Biological Therapies in Axial Spondyloarthritis. Gratacós J; Díaz Del Campo Fontecha P; Fernández-Carballido C; Juanola Roura X; Linares Ferrando LF; de Miguel Mendieta E; Muñoz Fernández S; Rosales-Alexander JL; Zarco Montejo P; Guerra Rodríguez M; Navarro Compán V Reumatol Clin (Engl Ed); 2018; 14(6):320-333. PubMed ID: 29050839 [TBL] [Abstract][Full Text] [Related]
15. Portuguese recommendations for the use of biological therapies in patients with axial spondyloarthritis - 2016 update. Machado P; Cerqueira M; Ávila-Ribeiro P; Aguiar R; Bernardo A; Sepriano A; Águeda A; Cordeiro A; Raposo A; Rodrigues AM; Barcelos A; Malcata A; Lopes C; Vaz CC; Nour D; Godinho F; Alvarenga F; Pimentel-Santos F; Canhão H; Santos H; Cunha I; Neves JS; Fonseca JE; Gomes JL; Tavares-Costa J; Costa L; Cunha-Miranda L; Maurício L; Cruz M; Afonso MC; Santos MJ; Bernardes M; Valente P; Figueira R; Pimenta S; Ramiro S; Pedrosa T; Costa TA; Vieira-Sousa E Acta Reumatol Port; 2017; 42(3):209-218. PubMed ID: 28894079 [TBL] [Abstract][Full Text] [Related]
16. Differential management of mild-to-severe psoriasis with biologic drugs: An Italian Delphi consensus expert panel. Girolomoni G; Altomare G; Ayala F; Berardesca E; Calzavara Pinton P; Chimenti S; Martini P; Peserico A; Puglisi Guerra A; Vena GA; J Dermatolog Treat; 2015 Apr; 26(2):128-33. PubMed ID: 24708158 [TBL] [Abstract][Full Text] [Related]
18. Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement. Olivieri I; Accorinti M; Abicca I; Bisceglia P; Cimino L; Latanza L; Leccese P; Lubrano E; Marchesoni A; Miserocchi E; Neri P; Salvarani C; Scarpa R; D'Angelo S; Rheumatol Int; 2018 Sep; 38(9):1727-1734. PubMed ID: 29961101 [TBL] [Abstract][Full Text] [Related]
19. Immediate treatment with tumour necrosis factor inhibitors in synthetic disease-modifying anti-rheumatic drugs-naïve patients with rheumatoid arthritis: results of a modified Italian Expert Consensus. Bortoluzzi A; Valesini G; D'Angelo S; Frediani B; Bazzichi L; Afeltra A; Paolazzi G; Doria A; Meroni PL; Govoni M Rheumatology (Oxford); 2018 Oct; 57(57 Suppl 7):vii32-vii41. PubMed ID: 30289538 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. de Winter JJ; van Mens LJ; van der Heijde D; Landewé R; Baeten DL Arthritis Res Ther; 2016 Sep; 18(1):196. PubMed ID: 27586785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]